Drug Profile
Botulinum toxin - Daewoong Pharmaceuticals
Alternative Names: Nabota 7S; Nabota NextLatest Information Update: 15 Dec 2021
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Antispasmodics; Bacterial proteins; Bacterial toxins; Muscle relaxants; Urologics
- Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Glabellar lines
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Glabellar-lines in South Korea (Parenteral, Injection)
- 06 Mar 2014 Early research in Glabellar lines in South Korea (Parenteral)